BackFSD Pharma Overview

FSD Pharma Total Liabilities

Track FSD Pharma's total liabilities ($5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$5.04M
↓ 13.89% YoYΔ $-813959.00 vs prior year quarter

Peer trimmed avg / median

Loading

FSD Pharma Total Liabilities History

Loading

FSD Pharma vs. peers: Total Liabilities Comparison

Loading

FSD Pharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

FSD Pharma (HUGE) FAQ

As of the most recent data (June 2024), HUGE shows a total liabilities of $5M. That compares with $5.9M in the prior-year period — down 13.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HUGE's total liabilities is now $5M (was $5.9M) — a 13.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether FSD Pharma is outperforming or lagging.

Tracking HUGE's total liabilities over time shows whether FSD Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $5M That compares with $5.9M in the prior-year period — down 13.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has FSD Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $5M) with ownership activity and broader fundamentals.

FSD Pharma's total liabilities is $5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.